ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Gastroenterology, Hepatology and Nutrition
Volume 13 - 2025 | doi: 10.3389/fped.2025.1607826
Clinical Efficacy of Simethicone Combined with Bifidobacterium in the Treatment of Pediatric Aerophagia
Provisionally accepted
- Department of Pediatrics, Anqing Municipal Hospital, Anqing City Hospital, Anqing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background:The causes of children aerophagia are complex, and the treatment methods are diverse. Moreover, it is prone to recurrent attacks. Simethicone oil, as a safe and new type of drug, can be used for treatment.To evaluate the clinical efficacy of simethicone combined with bifidobacterium for the treatment of pediatric aerophagia. Methods: This study evaluated two treatment approaches for aerophagia. The control group received monotherapy with Bifidobacterium, while the treatment group received combination therapy with Bifidobacterium and simethicone. Clinical efficacy, gastrointestinal symptom scores (GSRS), gastric motility parameters, and adverse events were compared between the two groups. Results: Among the 80 children with aerophagia,, 14 (17.5%) were preschool children, 56 (70%) were school-aged children and 10 (12.5%) were adolescents children. Seventy children (87.5%) had abdominal distension as their chief complaint. The treatment group exhibited a significantly higher clinical efficacy rate (92.5% vs. 75%, P < 0.05) and lower post-treatment GSRS scores (P < 0.05). Gastric emptying rates at 60 and 120 min were also significantly improved in the treatment group (P < 0.05), although no significant differences were observed in the serum gastrin or plasma motilin levels (P > 0.05).The rate of adverse events was 7.5% in the treatment group and 15% in the control group, with no statistically significant difference (P > 0.05). Conclusion: The combination of simethicone and bifidobacterium enhances gastric emptying, alleviates the clinical symptoms of pediatric aerophagia, and demonstrates favorable safety and tolerability, thereby supporting its clinical application.
Keywords: Simethicone, Bifidobacterium, Aerophagia, Chidren, Treat
Received: 08 Apr 2025; Accepted: 31 Jul 2025.
Copyright: © 2025 HE, Hu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ping HE, Department of Pediatrics, Anqing Municipal Hospital, Anqing City Hospital, Anqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.